News Daily News US Aortic Valve Trends in Older Patients Hint at Better Outcomes, Access L.A. McKeown November 23, 2021
News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021
News Conference News Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward Todd Neale November 16, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AHA 2021 Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE Shelley Wood November 14, 2021
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021
News Daily News Stressed Out Stable CAD Patients Have Higher Risk of MI and CV Death L.A. McKeown November 11, 2021
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
News Conference News TCT 2021 Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward Yael L. Maxwell November 06, 2021
News Conference News TCT 2021 GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF Michael O'Riordan November 06, 2021
News Conference News TCT 2021 More Complications With Plug Closure After TAVI: CHOICE-CLOSURE Michael O'Riordan November 05, 2021
News Conference News TCT 2021 TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3 Yael L. Maxwell November 05, 2021
News Daily News Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR Yael L. Maxwell November 03, 2021
News Daily News Stimulants Linked to Early Risk of CV Events in Elderly Michael O'Riordan October 25, 2021